Wall Street brokerages expect that Sharps Compliance Corp. (NASDAQ:SMED) will report $24.06 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Sharps Compliance’s earnings, with the highest sales estimate coming in at $25.94 million and the lowest estimate coming in at $22.90 million. Sharps Compliance reported sales of $12.57 million in the same quarter last year, which indicates a positive year-over-year growth rate of 91.4%. The firm is expected to announce its next quarterly earnings report on Wednesday, August 18th.
On average, analysts expect that Sharps Compliance will report full-year sales of $81.75 million for the current year, with estimates ranging from $80.60 million to $83.63 million. For the next fiscal year, analysts anticipate that the company will post sales of $83.28 million, with estimates ranging from $75.30 million to $101.11 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Sharps Compliance.
Sharps Compliance (NASDAQ:SMED) last announced its earnings results on Tuesday, April 27th. The industrial products company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.27. Sharps Compliance had a net margin of 2.54% and a return on equity of 4.50%. During the same quarter in the prior year, the business earned ($0.10) earnings per share.
In other news, VP Gregory C. Davis sold 2,719 shares of the firm’s stock in a transaction that occurred on Wednesday, May 5th. The shares were sold at an average price of $16.01, for a total transaction of $43,531.19. Following the completion of the transaction, the vice president now directly owns 805 shares of the company’s stock, valued at approximately $12,888.05. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO David P. Tusa sold 24,238 shares of the firm’s stock in a transaction that occurred on Thursday, May 13th. The stock was sold at an average price of $16.15, for a total transaction of $391,443.70. Following the transaction, the chief executive officer now directly owns 104,188 shares of the company’s stock, valued at $1,682,636.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 277,814 shares of company stock valued at $4,838,102. 15.10% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently modified their holdings of the company. Dorsey Wright & Associates purchased a new position in shares of Sharps Compliance during the 1st quarter worth approximately $45,000. Strs Ohio acquired a new stake in Sharps Compliance during the fourth quarter worth approximately $56,000. D L Carlson Investment Group Inc. acquired a new stake in Sharps Compliance during the fourth quarter worth approximately $118,000. C M Bidwell & Associates Ltd. acquired a new stake in Sharps Compliance during the first quarter worth approximately $122,000. Finally, GSA Capital Partners LLP acquired a new stake in Sharps Compliance during the fourth quarter worth approximately $168,000. 42.39% of the stock is owned by institutional investors and hedge funds.
Shares of SMED traded up $0.30 during mid-day trading on Friday, hitting $16.35. 257,799 shares of the company’s stock were exchanged, compared to its average volume of 193,289. Sharps Compliance has a fifty-two week low of $5.45 and a fifty-two week high of $18.67. The firm has a market capitalization of $276.17 million and a P/E ratio of 231.32. The business’s 50 day moving average is $14.83 and its two-hundred day moving average is $11.70. The company has a current ratio of 1.74, a quick ratio of 1.34 and a debt-to-equity ratio of 0.12.
About Sharps Compliance
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications.
Read More: Cash Flow Analysis in Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.